This review concluded that CT can detect calcification of the coronary arteries in asymptomatic patients, and the higher the coronary artery calcification score the higher the risk. Given the limitations of the available evidence and the lack of reporting of the details of the review methodology, the results should be viewed with caution.
Study selection
Primary studies of any design with screening for coronary heart disease (CHD) as the primary focus of the paper were eligible for inclusion if they compared CT to current practice (risk factor scoring) and included an intervention to modify risk in patients found to have coronary heart disease. When no such studies were located, studies that assessed the association between coronary artery calcification (CAC) scores on CT and outcomes in asymptomatic people were sought. Most of these studies used electron beam CT. The mean age of participants ranged from 50 to 65.7 years. Where reported, the proportion of patients with hypertension varied from 20% to 44%, hypercholesterolaemia 18% to 62%, smokers 10% to 48%, diabetes 3.4% to 6% and a family history of coronary heart disease from 21% to 69%. The cutoffs for coronary artery calcification scores and the events measured varied across the studies. It appeared that one reviewer reviewed titles and abstracts to assess initial relevance to the review and two reviewers independently reviewed titles and abstracts of the potentially relevant studies and full papers that were retrieved.
Assessment of study quality
The authors stated that study quality was assessed using a checklist from CRD Report 4. The authors did not state how many reviewers performed the validity assessment.
Data extraction
The number of deaths, cardiac events and invasive cardiac interventions were extracted from each study and the relative risk (RR) and 95% confidence intervals (CI) calculated. The authors stated neither how data were extracted for the review nor how many reviewers performed the data extraction.
Methods of synthesis
Pooled relative risks and 95% CIs for cardiac death or myocardial infarction were calculated (the meta-analytical method used was not reported). Statistical heterogeneity was assessed (the method used was not reported). The predicted rates of coronary death or non-fatal myocardial infarction for ranges of CT-determined coronary artery calcification scores were presented based on the Framingham risk score within each category.
Results of the review
No studies met the initial inclusion criteria. Seven studies assessed the association between coronary artery calcification scores on CT and outcomes in asymptomatic people (n=30,599; range 926 to 10,377). The results of the quality assessment were not presented. There was a significant increase in the overall risk of a cardiac event in patients with coronary artery calcification identified by CT (relative risk 3.5, 95% CI: 2.5 to 5.0); statistically significant heterogeneity was observed. Results for each outcome from each individual study were presented. Patients with a coronary artery calcification score of over 300 were at greater risk of coronary death or non-fatal myocardial infarction. The risk increased with increasing Framingham risk score, however, the number of patients with a coronary artery calcification score over 300 was small.
Cost information
For CT screening to be cost-effective it had to add value over risk-factor scoring by providing additional information to modify treatment and cardiac outcomes at an acceptable cost per quality-adjusted life year; there was no evidence to support this.
